Insider Transactions in Q3 2021 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$170,000
$34.01 P/Share
|
|
Sep 30
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.0 P/Share
|
|
Sep 15
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.69%
|
$160,000
$32.66 P/Share
|
|
Sep 15
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.69%
|
$30,000
$6.15 P/Share
|
|
Sep 09
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.29%
|
$62,000
$31.43 P/Share
|
|
Sep 02
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$165,000
$33.12 P/Share
|
|
Sep 02
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.3 P/Share
|
|
Sep 01
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
7,850
-5.15%
|
$251,200
$32.78 P/Share
|
|
Aug 18
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$155,000
$31.14 P/Share
|
|
Aug 18
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.3 P/Share
|
|
Aug 12
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.27%
|
$64,000
$32.6 P/Share
|
|
Aug 05
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$145,000
$29.12 P/Share
|
|
Aug 05
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.3 P/Share
|
|
Aug 02
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
2,616
-1.69%
|
$75,864
$29.67 P/Share
|
|
Jul 22
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$145,000
$29.82 P/Share
|
|
Jul 22
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.3 P/Share
|
|
Jul 19
2021
|
Sandford D Smith Director |
SELL
Open market or private sale
|
Direct |
11,965
-36.86%
|
$346,985
$29.0 P/Share
|
|
Jul 19
2021
|
Sandford D Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,965
+26.56%
|
$119,650
$10.68 P/Share
|
|
Jul 08
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.26%
|
$38,000
$19.48 P/Share
|
|
Jul 07
2021
|
Robert Califf Director |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.54%
|
$589
$19.77 P/Share
|
|
Jul 07
2021
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.97%
|
$1,197
$19.77 P/Share
|
|
Jul 07
2021
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.97%
|
$1,197
$19.77 P/Share
|
|
Jul 07
2021
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.54%
|
$589
$19.77 P/Share
|
|
Jul 07
2021
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.97%
|
$1,197
$19.77 P/Share
|
|
Jul 07
2021
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.48%
|
$1,197
$19.77 P/Share
|
|
Jul 06
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$100,000
$20.13 P/Share
|
|
Jul 06
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.3 P/Share
|
|
Jul 01
2021
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
476
+3.56%
|
$9,520
$20.98 P/Share
|
|
Jul 01
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
6,013
-3.73%
|
$114,247
$19.87 P/Share
|
|
Jul 01
2021
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
476
+6.93%
|
$9,520
$20.98 P/Share
|
|
Jul 01
2021
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
476
+6.93%
|
$9,520
$20.98 P/Share
|
|
Jul 01
2021
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
476
+6.93%
|
$9,520
$20.98 P/Share
|
|
Jul 01
2021
|
L Patrick Gage Director |
BUY
Grant, award, or other acquisition
|
Direct |
893
+3.05%
|
$17,860
$20.98 P/Share
|
|
Jul 01
2021
|
Robert Califf Director |
BUY
Grant, award, or other acquisition
|
Direct |
238
+4.01%
|
$4,760
$20.98 P/Share
|
|
Jul 01
2021
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
238
+4.01%
|
$4,760
$20.98 P/Share
|